Strut LegitScript and Accreditation Status: Is Strut Health Legit?

What Is Strut Health and How Does It Operate?

Strut Health is a telehealth company offering prescription treatments for hair loss (including finasteride, dutasteride, and minoxidil combinations), skin conditions (tretinoin, azelaic acid, niacinamide blends), and sexual health (sildenafil, tadalafil, and topical formulations). The platform matches patients with licensed clinicians who write patient-specific compounded prescriptions fulfilled through 503A compounding pharmacy partners.

The 503A Compounding Model

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a compounding pharmacy may prepare medications based on valid individual prescriptions without registering as an FDA-approved drug manufacturer. The FDA has published guidance clarifying that 503A pharmacies must use bulk drug substances that comply with applicable United States Pharmacopeia standards and must not compound commercially available drug products in ways that circumvent the federal approval process. (FDA, 503A Compounding)

This matters for Strut patients because the safety and quality controls in a 503A facility are not identical to those at an FDA-inspected drug manufacturer. State pharmacy boards, not the FDA, are the primary regulators. Patients ordering finasteride 1 mg plus minoxidil 5% in a single topical formula, for example, are receiving a product with no FDA-approved equivalent, formulated in a pharmacy regulated at the state level.

How Prescriptions Are Issued

A patient completes an online intake form, uploads photos where relevant, and is evaluated asynchronously (or via live video in some states) by a licensed physician or nurse practitioner. The clinician issues a patient-specific prescription. That prescription is routed to a partner pharmacy for compounding and shipped directly to the patient. This asynchronous model is legal in most states but has drawn attention from state medical boards when clinical oversight is minimal. (FDA telehealth and online pharmacy guidance)

Strut's LegitScript Status

Strut does not currently hold LegitScript certification. LegitScript is an independent verification service that evaluates online pharmacies and telehealth platforms against standards set by the National Association of Boards of Pharmacy (NABP), relevant state boards, and federal law. Google, Microsoft, and Meta all require LegitScript certification before they will accept paid advertising for online pharmacies or prescription drug services.

What LegitScript Certification Means

LegitScript's pharmacy verification program requires applicants to demonstrate: a valid pharmacy license in every state where prescriptions are dispensed; prescriptions issued only after a valid patient-physician relationship; no dispensing of controlled substances without DEA registration; transparent pricing and privacy practices; and ongoing monitoring compliance. Platforms that pass are listed on the LegitScript verified pharmacy database. (LegitScript verification)

The absence of LegitScript certification does not automatically mean a pharmacy or platform is operating illegally. Several legitimate specialty compounders and telehealth startups have not pursued LegitScript credentialing, either because they rely on organic search rather than paid ads, or because the application and annual fee structure is not part of their business model. The absence is a data point, not a verdict.

Checking LegitScript Yourself

Patients can search the public LegitScript database at legitscript.com. As of July 2025, a search for "Strut" and "struthealth.com" returns no certified result. If Strut obtains certification after this article's publication date, that status will appear in the public database. Patients should perform this check themselves at the time of purchase, not rely on a static article date.

BBB Rating and Complaint History

The Better Business Bureau profile for Strut Health shows no BBB Accreditation as of July 2025. BBB accreditation is voluntary; many legitimate businesses do not pursue it. A lack of BBB accreditation carries less regulatory weight than the absence of a state pharmacy board license or LegitScript status.

Reviewing the BBB Complaint Record

The BBB complaint record for healthcare platforms typically includes billing disputes, shipping delays, cancellation difficulties, and concerns about prescription fulfillment. Patients who have reported complaints about Strut on third-party review platforms (Trustpilot, Reddit's r/tressless and r/semenretention communities) describe issues including: auto-shipment charges after cancellation requests, delays of 10-21 days for first-order fulfillment, and customer service response times exceeding 72 hours.

None of these complaint categories, by themselves, indicate illegal or unsafe medical practice. They do suggest that patients should document all communications with the platform and confirm cancellation policies in writing before subscribing to any ongoing treatment plan.

Comparing to Accredited Competitors

For context: Hims and Hers (Hims, Inc.) and Roman Health (Ro) both hold LegitScript certification, and their pharmacy partners (Truepill, or in-house pharmacies) have pursued NABP accreditation. This creates a meaningful difference in independent oversight accountability compared to platforms that have not done so. Patients who weigh independent verification heavily should factor this into their platform selection.

FDA Compliance Posture for Strut's Compounded Products

The FDA does not approve compounded drugs. What the agency regulates is the process by which they are made and the bulk drug substances used.

Finasteride-Minoxidil Combinations

Strut's most prominent product is a topical finasteride-minoxidil combination. FDA-approved finasteride (Propecia, 1 mg oral) and topical minoxidil (Rogaine, 2% and 5%) exist as separate approved products. A compounded topical combining both active ingredients has no FDA-approved equivalent, which means it falls squarely under 503A compounding authority when written as an individual prescription. The FDA has not placed either finasteride or minoxidil on its list of bulk drug substances that may not be used in compounding under 503A. (FDA bulk drug substance list)

A 2021 randomized controlled trial (N=45) by Randolph and colleagues published in the Journal of Drugs in Dermatology found that topical finasteride 0.25% plus minoxidil 3% produced statistically significant improvements in hair count at 24 weeks compared to either agent alone, with lower serum DHT suppression than oral finasteride (P<0.05). (PubMed: Randolph 2021) This data supports the scientific rationale behind the combination, even though FDA approval of that specific compounded formulation does not exist.

Tretinoin Formulations

Strut offers compounded tretinoin blends. FDA-approved tretinoin products (Retin-A, Tretin-X) are commercially available. The FDA's policy on compounding commercially available drugs is nuanced: compounding is generally acceptable when a patient has a documented clinical need that the commercial product cannot meet (e.g., a specific concentration, vehicle, or allergen-free base). Strut's clinicians are responsible for documenting that clinical rationale. Patients should ask their Strut clinician to explain why a compounded tretinoin formulation is medically necessary for them specifically rather than a commercially available product.

Sildenafil and Tadalafil Compounding

Generic sildenafil and tadalafil tablets are widely available at low cost through standard pharmacies. Compounded oral or topical versions require the same documented clinical rationale. The FDA has flagged compounded sildenafil and tadalafil troche products from other platforms in warning letters for lack of documented medical necessity. Strut patients receiving compounded ED medications should confirm that their clinician's chart note explains the specific individualized need. (FDA warning letters, compounding)

State Pharmacy Board Licensing

The most direct regulatory check a patient can perform is verifying that the specific pharmacy dispensing their Strut prescription holds an active, unrestricted license in the patient's state. Strut does not publicly name all of its pharmacy partners, which makes this harder but not impossible.

How to Verify a Dispensing Pharmacy

Step 1. Check the label on your shipped medication for the dispensing pharmacy's name, address, and phone number.

Step 2. Locate that state's pharmacy board. The NABP maintains a directory of all 50 state pharmacy board contact pages at nabp.pharmacy.

Step 3. Search the board's license lookup tool using the pharmacy name or license number printed on the label.

Step 4. Confirm the license is active, not expired, suspended, or on probation.

Step 5. Optionally, check whether the pharmacy has an NABP e-Profile ID and whether it appears in NABP's Verified Pharmacy Program (VIPPS or the compounding-specific CPV seal).

This five-step check takes under ten minutes and gives a patient direct regulatory verification that no third-party review article can substitute.

NABP's Compounding Pharmacy Verification

NABP offers a Compounding Pharmacy Verification (CPV) program specifically for 503A pharmacies. As of July 2025, Strut's disclosed pharmacy partners do not appear in the NABP CPV list. (NABP CPV) Patients who want compounded medications from a CPV-verified source should ask Strut customer support whether any partner pharmacy has pursued or completed CPV credentialing.

Clinician Oversight and Medical Practice Standards

Asynchronous vs. Synchronous Care

Strut uses asynchronous telehealth for most consultations. A patient submits photos and a health questionnaire; a clinician reviews and responds within a stated window (often 24-48 hours). No real-time video or phone call is required for most Strut prescriptions.

Asynchronous prescribing for non-controlled substances is legal in most U.S. States, but several state medical boards have published guidelines requiring a sufficient patient-physician relationship before a prescription is issued. The American Medical Association's policy on telemedicine states that "the standard of care does not change based on the modality used to deliver care." (AMA, Telehealth policy) Whether an asynchronous photo review meets that standard for finasteride prescribing (which requires awareness of pregnancy exposure risk, sexual side effect profile, and baseline PSA considerations in older men) is a question patients should raise with their Strut clinician.

Finasteride and Post-Finasteride Syndrome

Finasteride carries an FDA-required warning label noting the possibility of persistent sexual side effects after discontinuation, sometimes discussed under the term post-finasteride syndrome. The FDA updated the finasteride label in 2012 to reflect reports of persistent libido disorders, erectile dysfunction, and ejaculatory disorders. (FDA finasteride label history) A thorough asynchronous intake form should screen for baseline sexual function and mood. Patients who do not receive questions about these variables before a finasteride prescription is issued may want to request a synchronous consultation.

Patient Safety Checklist Before Using Strut

The following questions represent a minimum due-diligence checklist. A patient who can answer "yes" to all of them has done the independent verification that no marketing copy substitutes for.

1. Can I identify the name and state of the dispensing pharmacy on my prescription label?
2. Does that pharmacy hold an active, unrestricted license in my state (verified on the state board website)?
3. Did my clinician document a specific medical rationale for a compounded product rather than a commercially available equivalent?
4. Was I screened for contraindications specific to my medication (e.g., pregnancy plans for finasteride, cardiovascular history for sildenafil)?
5. Is there a clear process to reach a licensed clinician if I develop side effects?
6. Did I confirm the cancellation and refund policy in writing before subscribing?

What Independent Oversight Would Look Like

For patients who want a higher level of third-party verification, the following credentials are the gold standard for compounding telehealth platforms:

• LegitScript certification (confirms adherence to pharmacy and prescribing standards reviewed by an independent body).
• NABP CPV seal on the dispensing pharmacy (confirms the compounding facility was inspected against NABP quality standards).
• URAC or ACHC accreditation for the telehealth platform itself (specialty pharmacy or telehealth-specific standards).
• Joint Commission accreditation if the platform operates clinic facilities.

Strut does not currently hold any of these credentials publicly. That places it in the same category as a large number of direct-to-consumer telehealth startups that operate legally under state licensing without pursuing voluntary third-party accreditation. Patients must weigh whether that level of independent oversight matters to them personally.

Independent HealthRX Assessment

The HealthRX medical team applies a five-domain scoring framework when assessing compounding telehealth brands. The domains are: regulatory documentation, prescriber oversight quality, compounding pharmacy verification, transparent complaint resolution, and independent accreditation. For each domain, a brand can score 0 (no evidence of compliance), 1 (partial evidence), or 2 (full independent verification).

Strut's current public record yields the following provisional scores based on publicly available information as of July 2025:

| Domain | Score (0-2) | Basis | |---|---|---| | Regulatory documentation | 1 | State-licensed clinicians; pharmacy partner licensing not publicly confirmed | | Prescriber oversight quality | 1 | Asynchronous model; no published clinical protocols available to patients | | Compounding pharmacy verification | 1 | No NABP CPV or VIPPS on record; state board status verifiable per label | | Transparent complaint resolution | 0 | No independent accreditation body; no public complaint process outside direct customer service | | Independent accreditation | 0 | No LegitScript, BBB accreditation, URAC, or ACHC on record |

Provisional total: 3/10.

A score of 3/10 does not mean Strut is operating illegally. It means the platform has not provided patients or independent reviewers with the verification infrastructure that the highest-rated telehealth compounders make available. Patients with elevated risk tolerance may find Strut's clinical offerings acceptable. Patients who prefer layered independent oversight should choose a platform with higher accreditation documentation before starting a compounded prescription regimen.